FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2026/04/109042 [Registered on: 21/04/2026] Trial Registered Prospectively
Last Modified On:
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Other (Specify) [Endoscopic ]  
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Comparison of different techniques for bile duct intervention using endoscopic ultrasound and needle knife method 
Scientific Title of Study   Endoscopic ultrasound guided rendezvous technique versus precut sphincterotomy as a salvage technique for difficult bile duct cannulation without inadvertent pancreatic duct cannulation: a randomized controlled trial 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Jayanta Samanta 
Designation  Additional Professor 
Affiliation  Postgraduate Institute of Medical Education and Research 
Address  Department of Gastroenterology, PGIMER, Chandigarh, Sector 12

Chandigarh
CHANDIGARH
160012
India 
Phone  9855319529  
Fax    
Email  dj_samanta@yahoo.co.in  
 
Details of Contact Person
Scientific Query
 
Name  Jayanta Samanta 
Designation  Additional Professor 
Affiliation  Postgraduate Institute of Medical Education and Research 
Address  Department of Gastroenterology, PGIMER, Chandigarh, Sector 12

Chandigarh
CHANDIGARH
160012
India 
Phone  9855319529  
Fax    
Email  dj_samanta@yahoo.co.in  
 
Details of Contact Person
Public Query
 
Name  Jayanta Samanta 
Designation  Additional Professor 
Affiliation  Postgraduate Institute of Medical Education and Research 
Address  Department of Gastroenterology, PGIMER, Chandigarh, Sector 12

Chandigarh
CHANDIGARH
160012
India 
Phone  9855319529  
Fax    
Email  dj_samanta@yahoo.co.in  
 
Source of Monetary or Material Support  
Department of Gastroenterology, Nehru Hospital, Postgraduate Institute of Medical Education and Research, Chandigarh, Sector 12, Chandigarh, 160012 
 
Primary Sponsor  
Name  Jayanta Samanta 
Address  Room 20, F Block, Level 1, Department of Gastroenterology, Nehru Hospital, Postgraduate Institute of Medical Education and Research, Chandigarh, Sector 12, Chandigarh, 160012 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Jayanta Samanta  Postgraduate Institute of Medical Education and Research, Chandigarh, India  Room no 20, Level I, Nehru Hospital, Department of Gastroenterology, PGIMER, Chandigarh - 160012
Chandigarh
CHANDIGARH 
9855319529

dj_samanta@yahoo.co.in 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Postgraduate Institute of Medical Education and Research, Chandigarh, Institute Ethics Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: K839||Disease of biliary tract, unspecified, (2) ICD-10 Condition: K87||Disorders of gallbladder, biliarytract and pancreas in diseases classified elsewhere,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Endoscopic ultrasound guided rendezvous technique (EUS-RV)  When standard ERCP fails, the patient randomised to this arm will be taken up for the procedure. This technique will be performed using using a linear array echoendoscope. First intraprocedural scanning will be done via EUS and assessment of regional vasculature will be done with colour doppler. Then, the bile duct will be punctured from D1-D2 junction with a 19-gauge FNA (fine needle aspiration) needle, and the confirmation of biliary access will be done by aspiration of bile through the needle. Once biliary access is confirmed, a 260-cm-long 0.025-inch hydrophilic guidewire will be inserted through the needle and directed in an anterograde manner downstream across the papilla into the duodenum. When the wire has been successfully manoeuvred down the common bile duct (CBD) to reach the duodenum, the needle will be withdrawn, followed by the echoendoscope. During withdrawal of the needle device, the standard exchange will be performed until the wire is entirely within the device. Once the needle device has been detached and entirely withdrawn from the echoendoscope, the echoendoscope will be withdrawn gradually during fluoroscopic visualization to ensure that the distal end of the wire remained within the distal duodenum. The duodenoscope (ERCP scope) will be then inserted alongside the EUS-placed guidewire until the second part of the duodenum is reached. Retrograde ERCP will be attempted parallel to the anterogradely placed guidewire with the help of a sphincterotome loaded with another guidewire. If this manoeuvre is not successful ,then the trans-papillary wire will be retrieved through the accessory channel of the duodenoscope with a snare/forceps. Once the guidewire is retrieved out of the accessory channel of the duodenoscope, a sphincterotome will be advanced over the wire for deep biliary cannulation. The time taken for the procedure will be documented.  
Comparator Agent  Pre-cut sphincterotomy   When standard ERCP fails, the patient randomised to this arm will be taken up for the procedure. This procedure will be performed with a needle knife papillotome, in which a thin diathermy wire that exits the catheter will be used to incise the papilla in an upward direction beginning from the orifice. The tip of the needle knife will be placed at the orifice of the papilla or slightly cephalad to the orifice and the cut will be performed cephalad along the proximal axis of the bile duct ans assessment of the area will be made, then the guidewire can be advanced into the orifice. If the bile is seen, the needle knife cannula with a preloaded wire or a sphincterotome with a preloaded wire will be advanced and probed gently in the orifice to gain access. Once the access is secured with a guidewire, and the bile duct is confirmed with contrast, the needle knife will be exchanged over the guidewire for a standard sphincterotome and procedure will be completed. The time taken for the procedure will be documented. 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  90.00 Year(s)
Gender  Both 
Details  Patients with naive papilla who require therapeutic ERCP
Benign biliary diseases
Extrahepatic biliary obstruction
All patients with difficult biliary cannulation during as per ESGE guidelines who have any one of the following
more than 5 contact with papilla while attempting to cannulate or more than 5 minutes spent to cannulate following visualisation of the papilla
Informed consent for participation in the study
 
 
ExclusionCriteria 
Details  Previously sphincteromized papilla
malignant biliary obstruction
Hilar block
past history of post ERCP pancreatitis
inadvertant pancreatic duct cannulation or contrast injection
unstable clinical conditions precluding EUS or ERCP
pregnant patient
lack of informed consent  
 
Method of Generating Random Sequence   Permuted block randomization, variable 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Participant and Outcome Assessor Blinded 
Primary Outcome  
Outcome  TimePoints 
To compare the rates of post ERCP pancreatitis between the two techniques   Within 2 weeks post procedure 
 
Secondary Outcome  
Outcome  TimePoints 
Technical success
overall adverse events
Rate of serious adverse events
Post procedure asymptomatic hyperamylasemia
time taken to achieve deep biliary cannulation
radiation expoure
hospital stay
need for second salvage procedure after failure of first salvage technique  

within 2 weeks of post procedure
within 2 weeks of post procedure
within 3-5 days post procedure
 
 
Target Sample Size   Total Sample Size="260"
Sample Size from India="260" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 3 
Date of First Enrollment (India)   30/05/2026 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="2"
Months="1"
Days="1" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - YES
  1. What data in particular will be shared?
    Response - Individual participant data that underlie the results reported in this article, after de-identification (text, tables, figures, and appendices).

  2. What additional supporting information will be shared?
    Response - None of the above

  3. Who will be able to view these files?
    Response - Researchers whose proposed use of the data has been approved by an independent review committee identified for this purpose.

  4. For what types of analyses will this data be available?
    Response - For individual participant data meta-analysis.

  5. By what mechanism will data be made available?
    Response - Proposals should be directed to [dj_samanta@yahoo.co.in].

  6. For how long will this data be available start date provided 31-12-2031 and end date provided 31-12-2034?
    Response - Beginning 9 months and ending 36 months following article publication.

  7. Any URL or additional information regarding plan/policy for sharing IPD? 
    Additional Information - Nil
Brief Summary   Endoscopic retrograde cholangiopancreatography (ERCP) is one of the most technically challenging procedures in the field of therapeutic endoscopy and remains the standard of care for the management of extrahepatic biliary obstruction (both benign and malignant causes). The prerequisite for defining the success of this procedure is to achieve deep biliary cannulation. Though there are advances in techniques and advanced endoscopic imaging, still 5 to 20% of cases of ERCP succumb to failure in biliary cannulation. The difficult cannulation (DBC) itself carries the increased risk of post ERCP complications, mainly post ERCP pancreatitis (PEP), bleeding and perforation. Various salvage techniques used to manage DBC are needle knife pre-cut papillotomy, double wire technique, trans-pancreatic septotomy and EUS guided rendezvous technique (EUS-RV). The conventional rescue strategy for DBC is to perform a pre-cut sphincterotomy or needle knife sphincterotomy, as endorsed even by various society guidelines. Only a single randomized controlled trial (RCT) exists comparing EUS-RV versus pre-cut sphincterotomy (PcP) in benign biliary diseases with DBC by Choudhury et al showed that there is no difference in the technical success rate (92% vs. 90%; P = 1.00) between the two techniques. Five patients (10%) in the EUS-RV group and 5 patients (10%) in the precut sphincterotomy group had developed post-endoscopic retrograde cholangiopancreatography pancreatitis. Interestingly, on exploratory analysis of the sub-cohort that did not have 1 or more inadvertent PD cannulation (n=72), it was noted that 2 (5.6% [CI, 0.6% to 17.3%) patients in the precut group had PEP, whereas none of the patients in the EUS-RV had PEP (relative risk, 0.21 [CI, 0.01 to 4.25]). But this study was not powered enough to answer this question. Through the findings of this study, one can speculate, that if guidewire has not entered the pancreatic duct (PD), EUS-RV has a “zero incidence” of PEP, which makes this procedure more attractive compared to other salvage ERCP techniques. Even though sub-group analysis is not available across published literature, Dhir et al and Dalal et al also reported zero PEP rates with the EUS-RV procedure, compared to pre-cut technique (2.8% and 8.7%), respectively. Both EUS-RV and PcP are techniques wherein direct papilla orifice contact is avoided, which can theoretically reduce or nullify the risk of PEP. So, in situations wherein, after encountering a difficult bile duct cannulation, where the pancreatic duct has not been cannulated inadvertently while performing ERCP, which salvage technique would prove to be better needs to be investigated. Hence, this randomized controlled trial has been designed to answer this question.

 
Close